Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 15, 2026 1 hour, 49 minutes ago
Thailand Medical: A new Thailand Medical Study is shedding light on a simple blood-based marker that could help improve understanding of tuberculosis, a disease that continues to affect millions worldwide. Researchers have found that levels of an immune-related enzyme known as adenosine deaminase, or ADA, are significantly elevated in individuals diagnosed with pulmonary tuberculosis.
Elevated ADA enzyme levels in blood reflect immune response linked to tuberculosis infection
Why Tuberculosis Remains a Global Threat
Tuberculosis, commonly referred to as TB, primarily affects the lungs and spreads through airborne droplets. Despite advances in medicine, it remains one of the leading infectious causes of death globally. Early diagnosis is critical, yet current testing methods can be slow, costly, or inaccessible in low-resource settings. Traditional diagnostic tools such as sputum microscopy and bacterial cultures often take time or lack sensitivity. More advanced molecular techniques exist, but their availability is limited in many parts of the world. This has driven scientists to search for simple, cost-effective biological markers that can support early detection and monitoring.
Understanding ADA and Its Role in the Body
Adenosine deaminase is an enzyme involved in the body’s immune response, particularly in activating T-lymphocytes - cells that play a central role in fighting infections. When the body is exposed to Mycobacterium tuberculosis, the bacteria responsible for TB, the immune system becomes highly active, leading to increased ADA production.
This biological response forms the basis of the new research, which explores whether ADA levels in the blood could reflect the presence of tuberculosis.
Key Findings from a Large Global Analysis
The study analyzed data from 34 independent studies conducted across multiple continents, offering a broad and diverse dataset.
The results showed a clear and consistent pattern. Patients with pulmonary tuberculosis had significantly higher serum ADA levels compared to both healthy individuals and those suffering from other respiratory diseases. The difference was substantial and statistically significant across nearly all included studies.
Importantly, the elevated ADA levels were observed regardless of geographic region or laboratory method used. This suggests that the increase in ADA is a fundamental biological response to TB infection rather than a result of external or technical factors.
A Promising Marker but Not a Standalone Test
While the findings are encouraging, researchers emphasize that ADA should not be used alone to diagnose tuberculosis. Elevated ADA levels indicate immune activation, but similar increases can occur in other conditions such as pneumonia, cancer, or inflammatory diseases.
This Medical News report highlights that ADA reflects the body’s response to infection rather than directly identifying the TB bacteria. Therefore, it should be considered as a supportive marker alongside established diagnostic methods.
Factors Influe
ncing ADA Levels
The study also revealed considerable variability in ADA levels among patients. Some individuals showed very high enzyme levels, while others had more moderate increases. This variation may be influenced by factors such as disease severity, bacterial load, nutritional status, and co-existing conditions like HIV.
Another challenge is the lack of standardized cutoff values for ADA levels. Different studies used different thresholds, making it difficult to establish a universal benchmark for clinical use.
Institutions Behind the Research
The
Thailand Medical research was conducted by scientists from the School of Allied Health Sciences, Walailak University, Thailand; the Center of Excellence Research for Melioidosis and Microorganisms, Walailak University, Thailand; the Faculty of Medicine, Mahasarakham University, Thailand; the Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok; and the Faculty of Science, Nakhon Phanom University, Thailand.
Implications for Future Healthcare
The findings suggest that serum ADA could play a role in improving TB screening and monitoring, particularly in settings where access to advanced diagnostics is limited. However, further research is needed to determine how best to integrate this marker into clinical practice.
Conclusion
In conclusion, this comprehensive analysis confirms that ADA levels are significantly elevated in individuals with pulmonary tuberculosis, reflecting a consistent and biologically meaningful immune response. However, despite its strong association with the disease, ADA cannot yet be considered a reliable diagnostic tool on its own. Its variability, overlap with other conditions, and lack of standardized thresholds limit its immediate clinical application. Future research must focus on refining its diagnostic accuracy, identifying optimal cutoff values, and understanding how it interacts with other clinical indicators to ensure safe and effective use in real-world healthcare settings.
The study findings were published in the peer reviewed International Journal of Environmental Research and Public Health.
https://www.mdpi.com/1660-4601/23/4/498
For the latest Thai Medical research, keep on logging to
Thailand Medical News.
Read Also:
https://www.thailandmedical.news/articles/thailand-medical
Share
Tweet
Share
